Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, March 1998, p. 171-175, Vol. 5, No. 2
Division of AIDS, STD, and TB Laboratory
Research, National Center for Infectious Diseases, Centers for Disease
Control and Prevention, Atlanta, Georgia 303331;
Ministry of Health and Environment, Nassau,
Bahamas2; and
Caribbean
Epidemiology Centre3 and
Ministry of
Health,4 Port-of-Spain, Trinidad and Tobago
Received 29 May 1997/Returned for modification 22 August
1997/Accepted 12 November 1997
Paired serum and oral-fluid (OF) specimens (n = 4,448) were collected from blood donors and patients
attending local sexually transmitted disease clinics in
Trinidad and Tobago and the Bahamas and were tested for the presence of
human immunodeficiency virus type 1 (HIV-1) antibodies. Sera were
tested by Abbott AB HIV-1/HIV-2 (rDNA) enzyme immunoassay (EIA),
and positive specimens were confirmed by Cambridge HIV-1 and HIV-2
Western blotting (WB). OF specimens were collected with the OraSure
collection device and were tested by Murex GACELISA and by two EIAs
from Organon Teknika (the Oral Fluid Vironostika HIV-1 Microelisa
System [OTC-L] and the Vironostika HIV-1 Microelisa System
[OTC-M]). EIA-reactive OF specimens were confirmed by
miniaturized WB (OFWB). GACELISA detected all 474 HIV-1 seropositive
specimens (sensitivity, 100%). OTC-L detected 470 positive specimens
(sensitivity, 99.2%), while OTC-M detected 468 positive specimens
(sensitivity, 98.8%). Specificities ranged from 99.2 to 100% for the
three assays. Concordance of OFWB with serum WB was 99.4%, and banding
patterns determined by the two methods were similar. The immunoglobulin
G (IgG) concentration of OF specimens ranged from 0.21 to 100 µg/ml,
with a mean of 17.1 µg/ml. Significant differences in OF IgG
concentrations were observed between HIV antibody-positive and HIV
antibody-negative persons (31.94 versus 15.28 µg/ml, respectively
[P < 0.0001]). These data further confirm the
suitability of OF specimens for detection of HIV-1 antibodies.
Currently available HIV-1 antibody assays provide sensitivities and
specificities with OF specimens comparable to those achieved with serum
specimens.
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Detection of Antibodies to Human Immunodeficiency Virus Type 1 in Oral Fluids: A Large-Scale Evaluation of Immunoassay
Performance
*
Corresponding author. Mailing address: Centers for
Disease Control and Prevention, 1600 Clifton Rd. D-12, Atlanta, GA
30333. Phone: (404) 639-3647. Fax: (404) 639-2660. E-mail:
TXG1{at}CDC.GOV.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»